We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific, Johnson & Johnson Announce Stent Trial Results for High-Risk Patients
Boston Scientific, Johnson & Johnson Announce Stent Trial Results for High-Risk Patients
May 27, 2005
America’s two largest drug-eluting stent makers presented promising results in clinical trials of their products in high-risk patients last week at the annual Paris Course on Revascularization (EuroPCR).